Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th

Rhea-AI Summary

Artelo Biosciences (NASDAQ: ARTL) announced its participation in the LD Micro Invitational XI, scheduled for June 8-10, 2021. Gregory D. Gorgas, President and CEO, will host a virtual presentation on June 9 at 1:00 p.m. EST. Artelo focuses on developing therapeutics that impact the endocannabinoid system to address unmet medical needs in conditions like cancer and PTSD. For further details and registration, visit the LD Micro Invitational XI event page.

LA JOLLA, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that management will present at the LD Micro Invitational XI investor conference taking place virtually June 8-10, 2021.

Gregory D. Gorgas, Artelo’s President and CEO, is scheduled to host a virtual presentation to investors during the event as follows:

2021 LD Micro Invitational XI
Date: Wednesday, June 9, 2021
Time: 1:00 p.m. EST / 10:00 a.m. PST – Track 1
Webcast: Sequire | Virtual Events (mysequire.com)

For more information on the LD Micro Invitational XI, or to register for the event, please visit https://ldmicrojune2021.mysequire.com.

About Artelo Biosciences
Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting endogenous signaling pathways including the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at www.artelobio.com and Twitter: @ArteloBio.

Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: ARTL@crescendo-ir.com

FAQ

When is Artelo Biosciences presenting at the LD Micro Invitational XI?

Artelo Biosciences will present on June 9, 2021, at 1:00 p.m. EST.

What is the focus of Artelo Biosciences?

Artelo Biosciences focuses on developing therapeutics that modulate the endocannabinoid system.

Where can I watch Artelo's presentation?

You can watch Artelo's presentation on the Sequire virtual events platform.

What is the significance of the LD Micro Invitational XI for ARTL?

The LD Micro Invitational XI is an important platform for ARTL to showcase their developments to investors.

How can I register for the LD Micro Invitational XI?

You can register for the LD Micro Invitational XI by visiting their official event page.